Archive | Next Phase Archive RSS feed for this section

Congratulations to the 4D Meets AI Innovator’s Pitch Challenge Winners!

25 Mar

By Joey Wong, Investor Research Analyst, LSN

Life Science Nation (LSN)’s 4D Meets AI partnering conference successfully concluded last Friday, March 19. Over the two-day event, LSN featured seven exceptional startup companies at the intersection of AI and life science through the Innovator’s Pitch Challenge (IPC).

Each company was featured on a dedicated landing page that hosted their pitch video and supplementary materials, and they participated in a live Q&A session with a panel of investor pitch judges. Conference attendees were able to visit these landing pages or join the live Q&A sessions, and they were encouraged to vote for their favorite IPC companies before the end of the conference.

Many thanks to all the IPC companies for their hard work promoting their technologies and to the pitch judges who supported each session with their feedback. Each company was judged on their supporting materials, as well as their live pitch and Q&A. Congratulations to Huma.AI and Thrive Bioscience for winning their sessions!

Huma.ai is a venture-backed healthcare AI company. It’s ML-enabled, questions and answers-driven knowledge automation platform turns domain experts into their own data scientists so that they can make real-time decisions driven by data. According to its customers, Huma.ai has cracked the Holy Grail.

Thrive is commercializing a family of instruments and software that provide previously unavailable data, imaging, analytics, and automation for cell culture, stem cell culture, and tissue culture for use in biomedical research and cell therapeutics. Thrive has recently started selling the first two instruments in the family, the CellAssist and the CellAssist 50. Both collect 1,000’s of images of live cells in culture, analyzes them, provides guidance and builds a significant database. The CellAssist 50 enables researchers to automatically and remotely image 50 plates of cells on an ongoing basis, generating large amounts of data for live cell biology. Sites include Harvard Stem Cell Institute, Center for Genomic Medicine (Massachusetts General Hospital), Stanford Stem Cell Core, University of Texas Medical Branch, as well as large and small pharma/biotech companies.

If you’re interested in the next upcoming Innovator’s Pitch Challenge, you can apply for the Digital RESI IPC taking place June 8-10. Applications close May 14!

This image has an empty alt attribute; its file name is digital-june-2021-banner-1100.png

Congratulations to the LHI Innovator’s Pitch Challenge Winners!

25 Mar

By Jessica Yang, Senior Research Analyst, Asia Business Development, LSN

Life Science Nation (LSN)’s 2-day Longevity, Health & Innovation (LHI) digital partnering conference took place March 18-19. We are very excited to announce the Top Winners of each Innovator’s Pitch Challenge (IPC) session. As the popularity grows for LHI IPC, we had three sessions featuring Therapeutics, Medical Devices & Diagnostics, and Digital Health companies. Attendees voted for their favorite companies based on materials available on the companies’ dedicated webpages, as well as their live pitch and Q&A.

Thank you to each IPC company for participating and sharing your technology and story with the LHI community. Congratulations to the winners, and thanks to all for voting!

Session 1 (Therapeutics) Tied Winners

APIE-Therapeutics, Inc is a preclinical stage biopharmaceutical company pioneering the endothelium vascular niche repair and regeneration platform. By harnessing activation of the Apelin-APJ receptor, we intend to improve patients’ lives suffering from chronic diseases such as Idiopathic Pulmonary Fibrosis (IPF), KidneyMembranous Glomerulonephritis (MGN) & Chronic Kidney Disease (CKD), Scleroderma (SSc) and others.

Panaceutics Rx uses its patented technologies to enable easy access to affordable personalized medicine and wellness, offering unique combination forms to improve adherence, delivered direct to patients. Our mission is to enable personalized combination products for prevention and chronic therapy, with aids to formulation based on an individual’s digital health profile. Individualized, optimized combinations are enabled to be made on-demand using our robotic platforms and patented processes. Under 503A regulatory rules, Panaceutics automates the compounding of individualized therapies to match physician’s prescriptions. We deliver individualized combination therapies in consumer-friendly forms that promote adherence.

Session 2 (Digital Health) Winner

LifeBio is an age-tech company that captures individuals’ life stories and increases social connectedness— to enhance mental health and to improve Alzheimer’s care.

Session 3 (Medical Devices & Diagnostics) Winner

Eye movements offer a window into brain health. neuroFit licensed a NASA-developed oculometric technology co-invented by one of our founders that delivers eye-movement-based metrics, some well-known from physiology (e.g., latency, acceleration, gain) and other more modern sensorimotor metrics (e.g., direction noise, speed tuning) distilled into a summary metric, nFit. Compared to biomarkers from imaging and EEG, oculometric approaches require only a visual display and a well-designed tracking system to yield noninvasive, low-cost biomarkers that can be scaled on consumer devices.

If you’re interested in the next upcoming Innovator’s Pitch Challenge, you can apply for the Digital RESI IPC taking place June 8-10. Applications close May 14!

This image has an empty alt attribute; its file name is digital-june-2021-banner-1100.png

Keep the Conversations Going

18 Mar

By Rory McCann, Marketing Manager & Conference Producer, LSN

Healthtech Partnering Week is off to the races! Digital RESI March has wrapped up with 1,000+ meetings in 3 days and leads into a triple-threat partnering experience consisting of 4D Meets AI, Access China Spring Forum (free), and Longevity, Health & Innovation taking place consecutively March 18-19.

It’s not too late to sign up and get involved in any of these three events! To learn more, visit the Healthtech Partnering Week website. Each conference offers unique opportunities suited for specific technology assets and market solutions. We hope you’ll join us and round out your RESI partnering with the full Healthtech Partnering Week experience!





Announcing the Digital RESI March Innovator’s Pitch Challenge (IPC) Winners

18 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireWe have successfully finished off our 3-Day Redefining Early Stage Investments (RESI) March Conference. As with our previous events, we had the pleasure of featuring over 30 innovative startup companies across therapeutics, medical devices, diagnostics, and digital health sectors through the Innovator’s Pitch Challenge (IPC).

I am very excited to announce to Top 3 winners of this IPC. Conference attendees were able to vote for their favorite companies based on the information on their dedicated page on the Digital RESI March Live Agenda, featuring a short pitch video, slide deck, executive summary, and other materials available for conference attendees to view. This Top 3 win is indicative of not only their innovative technology, but also their ability to present this in a cogent manner. The Top 3 winners will receive free tickets to future RESI conferences to help with their fundraising efforts.

The RESI Team would like to thank every IPC company for their hard work in preparing for these virtual presentations. We hope to continue the IPC as a unique platform for innovators and investors to connect, and we look forward to meeting and highlighting other innovative companies at future conferences, like Digital RESI, June 8-10.

Please check out the Top 3 Winners below!

First Place: Thrive Bioscience

Thrive is commercializing a family of instruments and software that provide previously unavailable data, imaging, analytics, and automation for cell culture, stem cell culture, and tissue culture for use in biomedical research and cell therapeutics. Thrive has recently started selling the first two instruments in the family, the CellAssist and the CellAssist 50. Both collect 1,000’s of images of live cells in culture, analyzes them, provides guidance and builds a significant database. The CellAssist 50 enables researchers to automatically and remotely image 50 plates of cells on an ongoing basis, generating large amounts of data for live cell biology. Sites include Harvard Stem Cell Institute, Center for Genomic Medicine (Massachusetts General Hospital), Stanford Stem Cell Core, University of Texas Medical Branch, as well as large and small pharma/biotech companies.

Second Place: modality.ai

Modality addresses the urgent need for objective and accurate biomarkers in the development of therapies for neurological and psychiatric disorders (such as autism, Parkinson’s, depression, etc.) Modality uses multimodal conversational AI extracting speech and facial measures to quantify the progression of such disorders in drug trials remotely – leading to faster completion, lowering failure rates, and increasing the ROI of drug development. In another market, Modality is used for Remote Patient Monitoring providing accurate, repeated metrics about the disease state of a physician’s patient base.

Third Place: SleepSpace

Proactive Life Inc (DBA SleepSpace) is a NYC based company using a universal experience — sleeping — to optimize health and wellness.
A few bullet points below:

  • $73B annual spending on sleep aids (1 in 3 American’s have a sleep disorder)
  • SleepSpace™ goes beyond tracking to actually help people sleep better
  • $3.4M booked revenues from NIH grants | $2.5M awarded in July 2020
  • D2C freemium model: 2,000+ paid subscribers (78% at $29.99 annually)
  • B2B paid contracts with Google & LIFX to build smart light sleep journeys
  • FDA Approval underway to change how doctors do remote patient care
  • Barriers to entry include AI algorithms and 4 utility patents (2 granted)
  • All-star team of sleep scientists, technologists, and exited entrepreneurs
  • $1M prior Angel round with Bascom Ventures, Lightspeed, Quake & UpVentures
  • Opening $2M Seed round with 87% allocated to scale proven acquisition funnel

Digital RESI March – A Most Impressive 3 Days

18 Mar

By Dennis Ford, Founder and CEO of Life Science Nation, Creator of the LSN Partnering Conference Series

Digital RESI March wrapped up yesterday after three days with 1,000+ face-to-face digital meetings. The who’s-who in early-stage global partnering came together virtually to source elite assets in life science and healthcare. The impressive lineup of global partners proves life science investing is thriving during the pandemic. With such an influx of promising technology and capital, we may truly be experiencing the golden age of life science. The message from the international partners who are seeking the fundraising executives to the scientist-entrepreneurs was clear, the game is afoot and opportunities for partnering abound!

The panels were diverse, informative and insightful with the current state of the state of early-stage global partnering. We look forward to sharing these insights with our audience!

If you missed this RESI, don’t worry. Digital RESI returns June 8-10 with an all-new lineup of investor panels, educational workshops, and of course, premier partnering with investors and strategic partners who are a fit for your product and stage of development.

If you’re an early-stage fundraising executive, you don’t want to miss out on the needle-moving conversations that take place at RESI. Our partnering platform assists founders to find investors and strategic partners that are a fit for their unique needs, and our many resources help entrepreneurs stand out with branding and messaging that showcase their team and technology.

Digital RESI June participants can sign up at the super early bird rate until April 9. Save $100 on registration and get partnering!

Introducing Healthtech Partnering Week Innovator’s Pitch Challenge Finalists

11 Mar

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

claireLife Science Nation (LSN) is pleased to announce next week’s Healthtech Partnering Week (HPW) Innovator’s Pitch Challenge finalists. The Innovator’s Pitch Challenge is an opportunity for early-stage companies to gain additional exposure to conference attendees, pitch directly to a panel of relevant investors, and participate in a live Q&A session.

Pitching opportunities at LSN partnering events are popular events for startups and investors alike. They provide exposure and experience to the companies, while providing investors with insight into the latest technology organized by sector and interest. Check out our finalists and select a logo to learn more about their participation. Registration is still open, so don’t miss out and sign up today!

Innovator’s Pitch Challenge Finalists

 

Announcing McDermott Will & Emery HPW Workshops

11 Mar

By Gregory Mannix, Vice President International Business Development, LSN

Life Science Nation (LSN) is thrilled to welcome McDermott Will & Emery as Title Sponsor of Healthtech Partnering Week (HPW) with two live workshops accessible to registered attendees of Redefining Early Stage Investments (RESI) and 4D Meets AI.

McDermott Will & Emery has brought valuable insights to LSN’s community of early-stage fundraising companies, investors, service providers, and strategic partnerships for years, and we look forward to bringing their content to the digital stage next week. There’s still time to register for HPW – Sign up for access to McDermott Will & Emery workshops and more!

Negotiating Term Sheets: What’s Best for the Company and What’s Best for You?
Live Workshop! March 16 | 1 PM EDT (Register for RESI Access)

Instructors:

  • Nancy Briefs, President & CEO, AltrixBio, Inc.
  • David Hendren, Managing Director, Augmentum Ventures
  • Mark Mihanovic, Partner, McDermott Will & Emery
  • Aroma Sharma, Partner, McDermott Will & Emery

This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion. Learn more!

How to Go to Market: Commercializing AI-Based Health Technologies
Live Workshop! March 19 | 10 AM EDT (Register for 4D Meets AI Access)

Instructors:

  • Richie Bavasso, MBA, Co-Founder & CEO, nQ Medical Inc.
  • Carolyn Metnick, JD, Partner, McDermott Will & Emery
  • Michael Ryan, JD, Partner, McDermott Will & Emery
  • Dale Van Demark, JD, Partner, McDermott Will & Emery

This workshop, hosted by our Title Sponsor McDermott Will & Emery, will focus on the various options for and the legal considerations involved with commercializing AI-based healthcare technologies, including regulatory and data strategies. Learn about the range of options, from R&D use to consumer products, from leading members of McDermott’s digital health practice and companies that have blazed the trail. Learn more!

%d bloggers like this: